Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR-62.0%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-62.0%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 1.31% |
| 2024 | -1.17% |
| 2023 | 9.69% |
| 2022 | 23.96% |
| 2021 | -31.16% |
| 2020 | -81.03% |
| 2019 | -295.60% |
| 2018 | 0.00% |